Introduction:
The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a focus on producing high-quality generic medications. Sumatriptan, commonly known by the brand name Imitrex, is a popular medication used to treat migraines. In this report, we will explore the top 10 Sumatriptan generic manufacturers in Israel, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Sumatriptan (Imitrex) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
– Market Share: 30%
– Teva is the largest pharmaceutical company in Israel and a global leader in generic medications. Their expertise in producing Sumatriptan generics has solidified their position at the top of the market.
2. Perrigo Company plc
– Market Share: 15%
– Perrigo is a key player in the Israeli pharmaceutical industry, specializing in affordable generic medications. Their Sumatriptan generics have gained popularity for their effectiveness and accessibility.
3. Mylan N.V.
– Market Share: 12%
– Mylan is known for its wide range of generic medications, including Sumatriptan. Their commitment to quality and affordability has made them a top choice for consumers in Israel.
4. Rafa Laboratories Ltd.
– Market Share: 8%
– Rafa Laboratories is a leading Israeli pharmaceutical company with a strong focus on generics. Their Sumatriptan products have garnered positive reviews for their efficacy and reliability.
5. Taro Pharmaceuticals Industries Ltd.
– Market Share: 7%
– Taro Pharmaceuticals is a well-established player in the Israeli pharmaceutical market, with a reputation for producing high-quality generics. Their Sumatriptan offerings have contributed to their success in the industry.
6. Dexcel Pharma Technologies Ltd.
– Market Share: 5%
– Dexcel Pharma is a dynamic pharmaceutical company in Israel, known for its innovative generic medications. Their Sumatriptan products have been well-received for their effectiveness and affordability.
7. Unipharm
– Market Share: 4%
– Unipharm is a prominent player in the Israeli pharmaceutical sector, specializing in a wide range of generics. Their Sumatriptan generics have gained traction in the market for their quality and competitive pricing.
8. Trima
– Market Share: 3%
– Trima is a growing pharmaceutical company in Israel, with a focus on producing affordable generics. Their Sumatriptan offerings have been well-received by consumers for their effectiveness and accessibility.
9. Biopharm
– Market Share: 2%
– Biopharm is a reputable pharmaceutical company in Israel, known for its commitment to producing high-quality generics. Their Sumatriptan products have helped solidify their position in the market.
10. Neopharm
– Market Share: 2%
– Neopharm is a key player in the Israeli pharmaceutical industry, with a diverse portfolio of generic medications. Their Sumatriptan generics have gained popularity for their efficacy and competitive pricing.
Insights:
The market for Sumatriptan generics in Israel is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of migraines and the demand for affordable medications. As more pharmaceutical companies invest in the production of generics, competition in the market is likely to intensify. It will be crucial for manufacturers to focus on innovation, quality, and cost-effectiveness to maintain their competitive edge. Additionally, partnerships and collaborations within the industry are expected to increase, leading to further advancements in Sumatriptan generics. Overall, the future looks promising for the Sumatriptan generic market in Israel, with ample opportunities for growth and development.
Related Analysis: View Previous Industry Report
